{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:27:24Z","timestamp":1786984044020,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.adro.2022.101125","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T10:33:55Z","timestamp":1669286035000},"page":"101125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["High-Risk Non-Small Cell Lung Cancer Treated With Active Scanning Proton Beam Radiation Therapy and Immunotherapy"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0957-0248","authenticated-orcid":false,"given":"Michael","family":"Carrasquilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitika","family":"Paudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian T.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Krochmal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Margolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahssan","family":"Balawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"DeBlois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Giaccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan W.","family":"Lischalk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2022.101125_bib0001","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa1916623","article-title":"The effect of advances in lung-cancer treatment on population mortality","volume":"383","author":"Howlader","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.adro.2022.101125_bib0002","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.adro.2022.101125_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-24223-1_1","article-title":"Lung cancer statistics","volume":"893","author":"Torre","year":"2016","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.adro.2022.101125_bib0004","doi-asserted-by":"crossref","first-page":"220","DOI":"10.21037\/tlcr.2018.05.06","article-title":"The epidemiology of lung cancer","volume":"7","author":"de Groot","year":"2018","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.adro.2022.101125_bib0005","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1470-2045(14)71207-0","volume":"16","author":"Bradley","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.adro.2022.101125_bib0006","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1200\/JCO.2016.69.1378","article-title":"Impact of intensity-modulated radiation therapy technique for locally advanced non-small-cell lung cancer: A secondary analysis of the NRG Oncology RTOG 0617 randomized clinical trial","volume":"35","author":"Chun","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2022.101125_bib0007","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ijrobp.2014.07.045","article-title":"Clinical implementation of intensity modulated proton therapy for thoracic malignancies","volume":"90","author":"Chang","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2022.101125_bib0008","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.ijrobp.2006.01.052","article-title":"Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in stage I or stage III non-small-cell lung cancer","volume":"65","author":"Chang","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2022.101125_bib0009","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/jrr\/rru082","article-title":"Comparison of dose-volume histograms between proton beam and X-ray conformal radiotherapy for locally advanced non-small-cell lung cancer","volume":"56","author":"Ohno","year":"2015","journal-title":"J Radiat Res"},{"key":"10.1016\/j.adro.2022.101125_bib0010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.radonc.2012.03.017","article-title":"Potentials of robust intensity modulated scanning proton plans for locally advanced lung cancer in comparison to intensity modulated photon plans","volume":"104","author":"Stuschke","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2022.101125_bib0011","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/jjco\/hyw108","article-title":"Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced non-small cell lung cancer","volume":"46","author":"Wu","year":"2016","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.adro.2022.101125_bib0012","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ijrobp.2009.04.028","volume":"77","author":"Zhang","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2022.101125_bib0013","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2017.2032","article-title":"Proton beam radiotherapy and concurrent chemotherapy for unresectable stage III non-small cell lung cancer: Final results of a phase 2 study","volume":"3","author":"Chang","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.adro.2022.101125_bib0014","first-page":"141","article-title":"Proton beam therapy in non-small cell lung cancer: State of the art","volume":"8","author":"Harada","year":"2017","journal-title":"Lung Cancer (Auckl)"},{"key":"10.1016\/j.adro.2022.101125_bib0015","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ijrobp.2015.11.004","article-title":"A phase 2 trial of concurrent chemotherapy and proton therapy for stage III non-small cell lung cancer: Results and reflections following early closure of a single-institution study","volume":"95","author":"Hoppe","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2022.101125_bib0016","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.cllc.2011.11.008","article-title":"Proton therapy with concurrent chemotherapy for non-small-cell lung cancer: Technique and early results","volume":"13","author":"Hoppe","year":"2012","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.adro.2022.101125_bib0017","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.radonc.2015.05.014","article-title":"Long-term outcomes after proton therapy, with concurrent chemotherapy, for stage II-III inoperable non-small cell lung cancer","volume":"115","author":"Nguyen","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2022.101125_bib0018","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","article-title":"Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer","volume":"377","author":"Antonia","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.adro.2022.101125_bib0019","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa1809697","article-title":"Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC","volume":"379","author":"Antonia","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.adro.2022.101125_bib0020","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1056\/NEJMoa1801005","article-title":"Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer","volume":"378","author":"Gandhi","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.adro.2022.101125_bib0021","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijrobp.2016.10.001","article-title":"National cancer database analysis of proton versus photon radiation therapy in non-small cell lung cancer","volume":"97","author":"Higgins","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2022.101125_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103365","article-title":"Mortality in adult patients with solid or hematological malignancies and SARS-CoV-2 infection with a specific focus on lung and breast cancers: A systematic review and meta-analysis","volume":"163","author":"Tagliamento","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.adro.2022.101125_bib0023","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13014-016-0640-8","article-title":"Establishing the feasibility of the dosimetric compliance criteria of RTOG 1308: Phase III randomized trial comparing overall survival after photon versus proton radiochemotherapy for inoperable stage II-IIIB NSCLC","volume":"11","author":"Giaddui","year":"2016","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.adro.2022.101125_bib0024","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.ijrobp.2021.07.1691","article-title":"Predictors of pneumonitis after conventionally fractionated radiotherapy for locally advanced lung cancer","volume":"111","author":"McFarlane","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2022.101125_bib0025","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1016\/j.prro.2020.09.014","article-title":"Clinical and dosimetric predictors of radiation pneumonitis in patients with non-small cell lung cancer undergoing postoperative radiation therapy","volume":"11","author":"Shepherd","year":"2021","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.adro.2022.101125_bib0026","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.5858\/arpa.2011-0521-OA","article-title":"Causes of death of patients with lung cancer","volume":"136","author":"Nichols","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.adro.2022.101125_bib0027","doi-asserted-by":"crossref","first-page":"114","DOI":"10.21037\/tlcr.2018.04.04","article-title":"Advanced proton beam dosimetry part II: Monte Carlo vs. pencil beam-based planning for lung cancer","volume":"7","author":"Maes","year":"2018","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.adro.2022.101125_bib0028","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.lungcan.2021.08.019","article-title":"Real-world survey of pneumonitis and its impact on durvalumab consolidation therapy in patients with non-small cell lung cancer who received chemoradiotherapy after durvalumab approval (HOPE-005\/CRIMSON)","volume":"161","author":"Saito","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/j.adro.2022.101125_bib0029","article-title":"Dynamic management of lung cancer care during surging COVID-19","volume":"8","author":"Wang","year":"2021","journal-title":"Front Surg"},{"key":"10.1016\/j.adro.2022.101125_bib0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2217\/lmt-2020-0012","article-title":"Lung cancer management challenges amidst COVID-19 pandemic: Hope lives here","volume":"9","author":"Shankar","year":"2020","journal-title":"Lung Cancer Manag"},{"key":"10.1016\/j.adro.2022.101125_bib0031","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/OP.20.00286","article-title":"Management of lung cancer during the COVID-19 pandemic","volume":"16","author":"Singh","year":"2020","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.adro.2022.101125_bib0032","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s13014-020-01631-2","article-title":"Two months of radiation oncology in the heart of Italian \u201cred zone\u201d during COVID-19 pandemic: Paving a safe path over thin ice","volume":"15","author":"Buglione","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.adro.2022.101125_bib0033","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.annonc.2020.06.007","article-title":"COVID-19 in patients with lung cancer","volume":"31","author":"Luo","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.adro.2022.101125_bib0034","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jtho.2020.10.013","article-title":"Toxicity and survival after intensity-modulated proton therapy versus passive scattering proton therapy for NSCLC","volume":"16","author":"Gjyshi","year":"2021","journal-title":"J Thorac Oncol"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109422002317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109422002317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:41:56Z","timestamp":1762530116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109422002317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2452109422002317"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2022.101125","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-Risk Non-Small Cell Lung Cancer Treated With Active Scanning Proton Beam Radiation Therapy and Immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2022.101125","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101125"}}